* Cardlytics Inc CDLX.OQ reported quarterly adjusted
earnings of
14 cents per share for the quarter ended in December, higher
than the same quarter last year, when the company reported EPS
of -29 cents. The mean expectation of three analysts for the
quarter was for earnings of 12 cents per share. Wall Street
expected results to range from 3 cents to 25 cents per share.
* Revenue rose 8.1% to $89.17 million from a year ago;
analysts
expected $89.55 million.
* Cardlytics Inc's reported EPS for the quarter was a loss
of
$2.56.
* The company reported a quarterly loss of $100.84 million.
* Cardlytics Inc shares had fallen by 6.6% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 84.6%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advertising &
marketing peer group is also "buy"
Wall Street's median 12-month price target for Cardlytics Inc is
$12.00
This summary was machine generated from LSEG data March 14 at
09:00 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 0.12 0.14 Beat
Sep. 30 2023 -0.01 0.01 Beat
Jun. 30 2023 -0.35 -0.24 Beat
Mar. 31 2023 -0.56 -0.25 Beat